May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Comparison of Radiation Dosage to Ocular Structures With Ru-106 and I-125 Plaques for Choroidal Melanoma
Author Affiliations & Notes
  • A. V. Chappelow
    Cleveland Clinic Foundation, Cleveland, Ohio
    Cole Eye Institute,
  • A. D. Singh
    Cleveland Clinic Foundation, Cleveland, Ohio
    Cole Eye Institute,
    Taussig Cancer Center,
  • D. A. Wilkinson
    Cleveland Clinic Foundation, Cleveland, Ohio
    Radiation Oncology,
  • M. Kolar
    Cleveland Clinic Foundation, Cleveland, Ohio
    Radiation Oncology,
  • P. Fleming
    Cleveland Clinic Foundation, Cleveland, Ohio
    Taussig Cancer Center,
    Radiation Oncology,
  • Footnotes
    Commercial Relationships A.V. Chappelow, None; A.D. Singh, None; D.A. Wilkinson, None; M. Kolar, None; P. Fleming, None.
  • Footnotes
    Support RESEARCH TO PREVENT BLINDNESS
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5235. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. V. Chappelow, A. D. Singh, D. A. Wilkinson, M. Kolar, P. Fleming; Comparison of Radiation Dosage to Ocular Structures With Ru-106 and I-125 Plaques for Choroidal Melanoma. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5235.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To compare radiation dosage to the macula, optic nerve head, lens, and sclera with Ru-106 or I-125 radiation plaques for choroidal melanoma.

Methods:: Using treatment planning software (Plaque Simulator; Bebig, Berlin, Germany), brachytherapy was simulated with each of two isotopes (Ru-106 and I-125) for 45 patients with choroidal melanoma 5mm or less in thickness. Plaque size and location varied based upon actual tumor size, but radiation dose to the tumor apex was held constant at 85 Gy. Radiation dosage to the optic nerve head, lens, macula and sclera was recorded for treatment simulations with both Ru-106 and I-125. Differences in radiation dosage between the two isotopes at each anatomic location were calculated and statistical significance evaluated with the paired two-sample t-test.

Results:: The mean dose to the optic nerve head, lens, and macula was 48% (p<0.0001), 82% (p<0.0001), and 14% (p=0.05) less with Ru-106 than with I-125, respectively. The inner and outer scleral doses were greater (17%, p<0.001; 29%, p<0.0001) for the beta-emitter Ru-106.

Conclusions:: In selected cases of choroidal melanoma (not exceeding 5mm in thickness), brachytherapy with Ru-106 (vs. I-125) significantly reduces radiation dosage to the optic nerve head, lens, and macula. Brachytherapy with Ru-106 may be associated with reduced risk of visual morbidity.

Keywords: radiation therapy • oncology • choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×